Carl Zeiss Meditec and Precise Bio to Develop Fabricated Corneal Tissue
Carl Zeiss Meditec, one of the world’s leading medical technology companies, and Precise Bio, a regenerative medicine company advancing the use of bio-printed tissues and organs, have entered into a partnership to develop and commercialize fabricated corneal tissue for transplants in patients that require endothelial keratoplasty and natural lenticule transplants for treating keratoconus and vision correction.